TrialEndocrine2025

"Tamoxifen for residual NF-PitNETs: A Proof-of-Concept study integrating receptor profiling, pilot trial, and target pathway analysis".

Amalina Haydar Ali Tajuddin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.